series-b
Stage
About
Cybrexa, Inc is a clinical-stage biotechnology company developing a novel tumor-targeting peptide-drug conjugate platform for targeted intracellular delivery of anti-cancer agents, aiming to improve cancer treatment outcomes across multiple solid tumor types.
Explore Cybrexa, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.